RESEARCH TRIANGLE INSTITUTE

• BATTELLE MEMORIAL INSTITUTE

  UEI F125YU6SWK59

  $2.5M

  Subcontractor to this prime · 4 sub-awards · latest Dec 1, 2025

  • Department of the Air Force
  • “WILL CONDUCT AEROSOL TESTING AGAINST CANDIDATE PROTOTYPE SUI”
  • “ADVANCE THE COMPONENT-LEVEL EVALUATION OF THE HOOD/MASK INTERFACE THAT ACCURATELY PREDICTS THE PROTECTION PERFORMANCE IN THE NECK AND HEAD REGIONS WHEN THE PROTECTIVE GARMENT SYSTEM IS TESTED AT THE COMPONENT LEVEL (I.E., HMI) AND PREDICTION OF PERFORMANCE WHEN TESTED AS A FULL ENSEMBLE ON A HUMAN.”
  • “BASE 8-IASTS EFFORT”
• AMERICAN INSTITUTES FOR RESEARCH IN THE BEHAVIORAL SCIENCES

  UEI MCN6J5L6M3T4

  $258.5K

  Subcontractor to this prime · 1 sub-award · latest Oct 23, 2025

  • Department of Education
  • “THE SUBCONTRACTOR WILL PROVIDE ONE STAFF MEMBER, ANDREAS ORANJE, WHO WILL SERVE AS PANEL CHAIR FOR THE NAEP VALIDITY PANEL. RESPONSIBILITIES INCLUDE:  PREPARE FOR AND MODERATE ALL FULL-PANEL MEETINGS.  PREPARE FOR AND ATTEND SPECIAL ADVISORY AND TECHNICAL EVALUATION WORKING GROUP MEETINGS AS NEEDED.  ATTEND WEEKLY CHECK-IN MEETINGS WITH AIR STAFF AND REGULAR CHECK-IN MEETINGS WITH NCES.  CONTRIBUTE TO AND REVIEW ALL EVALUATIONS AND, AS NEEDED, OTHER PANEL MATERIALS  LEAD THE SUMMARY EVALUATION WORKING GROUP AND CONTRIBUTE TO WRITING/REVIEWING THE SUMMARY EVALUATION REPORT.  WRITE SPECIAL ADVISORY MEETING MEMOS WITH SUPPORT FROM AIR.”
• TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE

  UEI GM1XX56LEP58

  $155.6K

  Subcontractor to this prime · 1 sub-award · latest Jul 7, 2025

  • Defense Health Agency
  • “RTI STATEMENT OF WORK RTI INTERNATIONAL WILL PROVIDE SUPPORT FOR THE PROTOCOL “DOSE-FINDING STUDY OF SILDENAFIL FOR THE TREATMENT FOR CHRONIC TRAUMATIC CEREBOVASCULAR INJURY (TCVI)” THE PROPOSED WORK INVOLVES DEVELOPMENT, IMPLEMENTATION, ANALYSIS, AND REPORTING OF AN EARLY PHASE RANDOMIZED, CLINICAL TRIAL TO DETERMINE THE OPTIMAL PDE5 INHIBITOR DOSE TO IMPROVE OR NORMALIZE MICROVASCULAR FUNCTION (ΔCVR MEASURE) AFTER A SINGLE PDE5 INHIBITOR OR PLACEBO DOSE (DOSE RANGE SILDENAFIL 20-80 MG) IN 160 CHRONIC TBI PATIENTS; TO ASSESS THE SAFETY AND TOLERABILITY OF A RANGE OF PDE5 INHIBITOR DOSES (PLACEBO, SILDENAFIL 20, 40, 80 MG TID) IN 160 CHRONIC TBI SUBJECTS; AND TO MEASURE THE EFFECT OF CHRONIC (4-WEEK) PDE-5 INHIBITOR ADMINISTRATION AT 3 DIFFERENT DOSES COMPARED TO PLACEBO ON TBI SYMPTOM AND OUTCOME MEASURES. THE 48-MONTH TRIAL WILL BE CONDUCTED AT 2 CLINICAL SITES AND RTI WILL ACT AS THE DATA COORDINATING CENTER RESPONSIBLE FOR PROVIDING SUPPORT FOR BIOSTATISTICS AND DATA MANAGEMENT DURING THE DURATION OF THE STUDY. AS PART OF THIS SUPPORT, RTI WILL CONTINUE TO PROVIDE STUDY PLANNING SUPPORT INCLUDING UPDATING THE STUDY PROTOCOL, ANALYSIS PLAN, AND DATA MANAGEMENT PLAN AS NEEDED; DESIGNING AND IMPLEMENTING THE RANDOMIZATION SCHEME FOR THE PROPOSED STUDY; DEVELOPING THE CASE REPORT FORMS AND ASSOCIATED ELECTRONIC DATA CAPTURE (EDC) SYSTEM; PROVIDING INPUT AS NEEDED TO OTHER STUDY MATERIALS SUCH AS TRAINING DOCUMENTS AND THE MANUAL OF PROCEDURES; AND IDENTIFYING FITBIR REPORTING REQUIREMENTS. DURING THE STUDY, RTI WILL PROVIDE ONGOING DATA MANAGEMENT INCLUDING MAINTENANCE OF THE EDC AND ONGOING QUERY IDENTIFICATION AND MANAGEMENT; CREATE AND DISTRIBUTE STUDY STATUS REPORTS INCLUDING MANAGEMENT REPORTS FOR THE STEERING COMMITTEE (I.E. ABOUT RECRUITMENT AND RETENTION AS WELL AS DATA QUALITY AND COMPLETENESS) AND THE DATA AND SAFETY MONITORING BOARD; AND CREATE FITBIR COMPLIANT DATASETS AND DOCUMENTATION AND UPLOAD DATA TO FITBIR IN COMPLIANCE WITH REQUIREMENTS. FINALLY,”

• TELLIGEN, INC

  UEI W9H9TLXLZCL7

  $16.3M

  Subcontracted by this company · 6 sub-awards · latest Mar 19, 2025

  • Centers for Medicare and Medicaid Services
  • “5-312-0217152 MOD 1 $6,663,242 DTD 3-19-2025 AND MOD 2 (DEOBLIG) DTD 6-19-2025 $4,759,585 = 1,903,657”
  • “2-312-0217152 MOD 3”
  • “SUBCONTRACT 37-312-0214448 MOD 9”
• HR DIRECTIONS LLC

  UEI TR5MFWK12CW6

  $7.2M

  Subcontracted by this company · 4 sub-awards · latest Dec 17, 2024

  • Department of Education

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.